Industry: Biotechnology
Article
The Mother of All Binary Events Might End in an…
Jul 22, 2021
Deciphera Pharmaceuticals is nearing the most important data readout in its history.
By Maxx Chatsko
Premium Advisor Update
7investing Biotech Recs: The Next De-Risking Events
Jul 15, 2021
By Maxx Chatsko
Article
RNAi is Setting a High Bar for Gene Editing
Jun 23, 2021
In the second quarter, three different RNAi drug candidates or drug products demonstrated the ability to reverse three different diseases.
By Maxx Chatsko
Article
What Makes a Biotech 10-Bagger?
Jun 21, 2021
You don't necessarily have to sift through microcaps. You do need to focus on the right metrics. Maxx Chatsko offers his perspective.
By Maxx Chatsko
Premium Advisor Update
Can Better Antibodies Challenge Cell Therapy?
Jun 14, 2021
By Maxx Chatsko
Article
Are Psychedelics the Future of Neuroscience?
Apr 27, 2021
Investors are increasingly excited about this emerging space, but must be mindful of valuation and clinical risks.
Biotechnology
Article
Can the Bioeconomy Transform Argentina into a Regional Superpower?
Apr 22, 2021
Maxx Chatsko notes that while all eyes are on Brazil, the geographic strengths of its southern neighbor cannot be overlooked.
By Maxx Chatsko
Premium Advisor Update
Running with Scissors: Will CRISPR be Humbled in the Clinic?
Apr 13, 2021
By Maxx Chatsko
Article
Welcome Dana Abramovitz to 7investing!
Apr 12, 2021
7investing is excited to welcome Dana Abramovitz as its newest lead advisor. Come read a bit about her background in biochemistry and her incredible passion for health care.
Biotechnology
Video
Maxx’s Top Stock for April 2021
Apr 1, 2021
7investing Lead Advisor Maxx Chatsko's Top Stock to buy in April 2021 is developing a genetic medicine platform with several key advantages over peers.
By Maxx Chatsko
Premium Advisor Update
My Long-Term Strategy in a Volatile Market
Mar 15, 2021
By Maxx Chatsko
Video
Manisha’s Top Stock for March 2021
Mar 1, 2021
Manisha's Top Stock for March 2021 is an under-the-radar microbiome company with a revolutionary technology platform.
By Manisha Samy
Article
A Mission Statement is Easy. Execution is Difficult
Feb 22, 2021
A mission statement is nice to have, but it too often becomes a marketing pitch. Progress, including within a company's mission, is more important for investors.
By Maxx Chatsko
Premium Advisor Update
Most Investors Neglect One of Their Biggest Advantages
Feb 14, 2021
By Maxx Chatsko
Video
Maxx’s Top Stock for February 2021
Feb 1, 2021
7investing Lead Advisor Maxx Chatsko's Top Stock for February is an early-stage biopharma attempting to fundamentally change drug discovery and drug development.
By Maxx Chatsko
Article
Genomics Isn’t the Only Omics
Jan 22, 2021
Maxx discusses misconceptions surrounding one of the market's oft-used buzzwords.
By Maxx Chatsko
Video
Manisha’s Top Stock for January
Jan 1, 2021
7investing Lead Advisor Manisha Samy’s Top Stock for January is applying breakthrough technologies towards providing one-course treatments for rare, life-threatening diseases.
By Manisha Samy
Video
Maxx’s Top Stock for January
Jan 1, 2021
7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic...
By Maxx Chatsko
Article
Does the “B” Word Apply? It’s Complicated
Dec 22, 2020
Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks.
By Maxx Chatsko
